NCT05063604

Antidepressant Efficacy of Psychotherapy and Citalopram in Patients With Breast Cancer and Major Depression

Randomized, Controlled, Open and Unicentric Phase II Clinical Trial, With Two Parallel Groups, to Evaluate the Antidepressant Efficacy of Psychotherapy and Citalopram in Women Diagnosed With Breast Cancer and Major Depression

• Status: Terminated
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Hospital Universitari de Bellvitge · Academic / Other
• Sex: Female
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

To provide evidence on the antidepressant efficacy of two therapeutic treatments: pharmacological treatment (citalopram) and psychotherapy treatment, in women diagnosed with breast cancer and major depression.

Conditions

• Breast Cancer
• Major Depressive Episode

Interventions

Type	Name	Description
DRUG	Citalopram	20 mg tablet one or twice daily for 12 weeks
BEHAVIORAL	Psychotherapy	One session weekly for 12 weeks

Timeline

• Start date: 2022-05-10
• Primary completion: 2022-05-10
• Completion: 2022-06-29
• First posted: 2021-10-01
• Last updated: 2022-07-05

Locations

1 site across 1 country: Spain